n Obstetrics and Gynaecology Forum - Longest-ever study of post-menopausal osteoporosis therapy : product news
|Article Title||Longest-ever study of post-menopausal osteoporosis therapy : product news|
|© Publisher:||In House Publications|
|Journal||Obstetrics and Gynaecology Forum|
|Publication Date||Oct 2005|
Extracted from text ... Obstetrics & Gynaecology Forum ? October 2005 27 Longest-Ever Study of Post-Menopausal Osteoporosis Therapy In the longest, randomised clinical trial ever conducted of treatment for osteoporosis, researchers found that post-menopausal women taking FOSAMAX(r) (alendronate sodium) experienced significant (p < 0.001) increases in bone mineral density (BMD) at the hip and spine at 10 years of treatment. FOSAMAX is the most-prescribed medicine worldwide for the treatment of postmenopausal, male and glucocorticoid-induced osteoporosis with more than 20 million patient years of therapy prescribed. FOSAMAX is the only osteoporosis therapy with proven efficacy through ten years. "Assessing the effect of treatment over time ..
Article metrics loading...